Edition:
United States

Novozymes A/S (NVZMY.PK)

NVZMY.PK on OTC Markets Group

47.14USD
18 Aug 2017
Change (% chg)

$0.01 (+0.02%)
Prev Close
$47.13
Open
$47.19
Day's High
$47.25
Day's Low
$47.02
Volume
55,661
Avg. Vol
23,463
52-wk High
$47.32
52-wk Low
$31.57

NVZMY.PK

Chart for NVZMY.PK

About

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and... (more)

Overall

No Ratios Available.

Financials

  NVZMY.PK Industry Sector
P/E (TTM): -- 18.91 45.68
EPS (TTM): -- -- --
ROI: -- 18.26 9.20
ROE: -- 26.05 11.80

BRIEF-Novozymes launches two ethanol enzyme products in Europe

Aug 17 DANISH ENZYMES PRODUCER NOVOZYMES ANNOUNCES

Aug 17 2017

Novozymes shares fall as Q2 pressured by detergent makers, Monsanto alliance

COPENHAGEN, Aug 11 Danish enzymes maker Novozymes undershot market expectations in the second quarter pressured by cost cuts at detergent makers and a changed sales pattern in its cooperation with Monsanto.

Aug 11 2017

BRIEF-Novozymes ‍Q2 EBIT at DKK ‍​963 mln, below expectations

* ‍Q2 EBIT MARGIN AT 28.2%, EXCLUDING REORGANIZATION COSTS (Q2 2016: 28.0%)​

Aug 11 2017

BRIEF-Novozymes CFO steps down

* BENNY D. LOFT TO STEP DOWN AS CFO AND EXECUTIVE VICE PRESIDENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 15 2017

BRIEF-Novozymes says co, Heinz-Jürgen Bertram mutually decided that he will resign from co's board with effect as of June 8, 2017

* Novozymes - Co, Heinz-Jürgen Bertram have mutually decided that Heinz-Jürgen Bertram will resign from Novozymes' board with effect as of June 8, 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Jun 08 2017

REFILE-UPDATE 1-Novozymes shares rise to 9-month high after Q1 earnings

April 26 Danish enzymes maker Novozymes posted slightly better-than-expected revenues for the first quarter on Wednesday and said it would launch a new product in the autumn, sending its shares up more than 5 percent to a nine-month high.

Apr 26 2017

BRIEF-Novozymes Q1 EBIT up at DKK 1.01 billion, in line with expectations

* "GOOD START TO 2017 WITH PROGRESS ON OUR STRATEGIC PRIORITIES."

Apr 26 2017

Denmark's Novo A/S ups Synlab stake to 20 pct before possible IPO

COPENHAGEN, April 12 Danish life science investor Novo A/S said on Wednesday it was raising its stake in Synlab to about 20 percent through a 250 million euro ($265 million) subscription to new shares, ahead of a potential listing of Europe's second largest lab operator.

Apr 12 2017

BRIEF-Novozymes, Boehringer announce strategic collaboration in probiotics for poultry hatcheries

* Novozymes and Boehringer Ingelheim announce strategic collaboration in probiotics for poultry hatcheries

Mar 30 2017

BRIEF-Dong Energy to build biogas plant for Novo Nordisk, Novozymes residues

* Says will in cooperation with Bigadan build a large-scale biogas plant

Mar 23 2017

Earnings vs. Estimates